Tremblay JP - Search Results

1

Current Clinical Applications of In Vivo Gene Therapy with AAVs.

Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, Goodspeed K, Gray SJ, Kay CN, Boye SL, Boye SE, George LA, Salabarria S, Corti M, Byrne BJ, Tremblay JP. Mendell JR, et al. Among authors: tremblay jp. Mol Ther. 2021 Feb 3;29(2):464-488. doi: 10.1016/j.ymthe.2020.12.007. Epub 2020 Dec 10. Mol Ther. 2021. PMID: 33309881 Free PMC article. Review.

2

Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts.

Quenneville SP, Chapdelaine P, Rousseau J, Beaulieu J, Caron NJ, Skuk D, Mills P, Olivares EC, Calos MP, Tremblay JP. Quenneville SP, et al. Among authors: tremblay jp. Mol Ther. 2004 Oct;10(4):679-87. doi: 10.1016/j.ymthe.2004.05.034. Mol Ther. 2004. PMID: 15451452 Free article.

3

Ex vivo modification of cells to induce a muscle-based expression.

Quenneville SP, Tremblay JP. Quenneville SP, et al. Among authors: tremblay jp. Curr Gene Ther. 2006 Dec;6(6):625-32. doi: 10.2174/156652306779010651. Curr Gene Ther. 2006. PMID: 17168695 Review.

4

Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.

Quenneville SP, Chapdelaine P, Skuk D, Paradis M, Goulet M, Rousseau J, Xiao X, Garcia L, Tremblay JP. Quenneville SP, et al. Among authors: tremblay jp. Mol Ther. 2007 Feb;15(2):431-8. doi: 10.1038/sj.mt.6300047. Mol Ther. 2007. PMID: 17235323 Free article.

5

Another new "super muscle stem cell" leaves unaddressed the real problems of cell therapy for duchenne muscular dystrophy.

Tremblay JP, Skuk D. Tremblay JP, et al. Mol Ther. 2008 Dec;16(12):1907-9. doi: 10.1038/mt.2008.243. Mol Ther. 2008. PMID: 19023271 Free article. No abstract available.

6

A case for immunosuppression for myoblast transplantation in duchenne muscular dystrophy.

Tremblay JP, Skuk D, Palmieri B, Rothstein DM. Tremblay JP, et al. Mol Ther. 2009 Jul;17(7):1122-4. doi: 10.1038/mt.2009.125. Mol Ther. 2009. PMID: 19564866 Free PMC article. No abstract available.

7

Expression of dog microdystrophin in mouse and dog muscles by gene therapy.

Pichavant C, Chapdelaine P, Cerri DG, Dominique JC, Quenneville SP, Skuk D, Kornegay JN, Bizario JC, Xiao X, Tremblay JP. Pichavant C, et al. Among authors: tremblay jp. Mol Ther. 2010 May;18(5):1002-9. doi: 10.1038/mt.2010.23. Epub 2010 Feb 23. Mol Ther. 2010. PMID: 20179674 Free PMC article.

8

Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy.

Goudenege S, Lamarre Y, Dumont N, Rousseau J, Frenette J, Skuk D, Tremblay JP. Goudenege S, et al. Among authors: tremblay jp. Mol Ther. 2010 Dec;18(12):2155-63. doi: 10.1038/mt.2010.165. Epub 2010 Aug 3. Mol Ther. 2010. PMID: 20683444 Free PMC article.

9

Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.

Fakhfakh R, Michaud A, Tremblay JP. Fakhfakh R, et al. Among authors: tremblay jp. Mol Ther. 2011 Jan;19(1):204-10. doi: 10.1038/mt.2010.171. Epub 2010 Aug 10. Mol Ther. 2011. PMID: 20700111 Free PMC article.

10

Not an inside job: how can transplantation of relatively few exogenous satellite cells do what thousands of endogenous cells cannot?

Tremblay JP, Skuk D, Frederickson R. Tremblay JP, et al. Mol Ther. 2011 Jan;19(1):6-8. doi: 10.1038/mt.2010.276. Mol Ther. 2011. PMID: 21200393 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page